Thomas Helbich Selected Research

Thomas Helbich Research Topics

7	Breast Neoplasms (Breast Cancer) 03/2024 - 05/2002
6	Neoplasms (Cancer) 12/2023 - 11/2003
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 04/2006
1	Hypertrophy 02/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Pulmonary Hypertension 01/2020
1	Ductal Carcinoma 10/2019
1	Hypoxia (Hypoxemia) 01/2018
1	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2015
1	Body Weight (Weight, Body) 05/2014
1	Inflammatory Breast Neoplasms 05/2010
1	Hemangioma (Angioma) 12/2002
1	Cicatrix (Scar) 12/2002
1	Neoplasm Metastasis (Metastasis) 12/2002
1	Focal Nodular Hyperplasia 12/2002

4	Contrast MediaIBA 03/2024 - 12/2002
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 02/2015
2	fluoromisonidazoleIBA 01/2018 - 12/2017
2	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 11/2003 - 05/2002
1	Indicators and Reagents (Reagents)IBA 03/2024
1	IodineIBA 12/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023
1	TenascinIBA 02/2021
1	IronIBA 01/2021
1	ferric chlorideIBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2019
1	gadoterate meglumineIBA 05/2014
1	N,N'- bis(pyridoxal- 5- phosphate)ethylenediamine- N,N'- diacetic acid (mangafodipir)FDA Link 12/2002
1	ferumoxides (Feridex)FDA Link 12/2002
1	GadoliniumIBA 12/2002
1	ferric oxide (iron oxide)IBA 12/2002